chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient arrived at clinic today to get a Moderna Bivalent Booster and a Flu vaccine. In between doses he startd to feel light headed and did not say anything initially.  After 2nd dose (flu) he let the vaccinator know.  Pt was c/o feeling lightheaded, pale and sweaty.  Provided patient with PFA, water and a snack.  Within just a couple of minutes he was feeling much better.  Continued to monitor patient for another few minutes.
None. Reporting the incident as a vaccine was not administered per age indication. Mother notified the same evening as the vaccine given. Infant w/o any reaction nor fevers nor rashes nor irritability reported.
Just a little swoleness under my right arm, possibly lymph nodes.  Upper arm  at injection site is also sore.
Covid-19 (confirmed by positive COVID-19 test); Covid-19 (confirmed by positive COVID-19 test); came in contact with someone who tested positive; This is a spontaneous report from a contactable consumer. An 85-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ), via an unspecified route of administration, on 11Feb2021 (at the age of 85-years) as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient came in contact with someone who tested positive, now she also tested positive. The clinical course was as follows: The consumer calling on behalf of her friend who is 85 years old who received the first dose of Pfizer's COVID vaccine on 11Feb2021. 2 weeks after she got the first shot, she came in contact with someone who tested positive. She also tested positive and was asymptomatic and in isolation. The consumer heard the patient cannot receive the second dose until after 90 days and is asking if this is true. The patient had lab tests which included sars-cov-2 test: positive on unspecified date.  The clinical outcome of she also tested positive (sars-cov-2 test positive) was unknown.  Information on the lot number has been requested.
Pt began to have symptoms which were thought to be dandruff but after going to dermatologist on 7/2, she has been diagnosed with psoriasis. I am reporting as this is an autoimmune disease with no genetic history.   This is the second of three children who have been diagnosed with an autoimmune disorder either during pandemic/vaccination; the other being type 1 diabetes with no genetic history.  Confirmed through multiple tests. Other child age was 13 at time of diagnosis .   Maybe unrelated but I did believe that any autoimmune diseases diagnosed after a vaccination that is to provide an autoimmune response to a disease  should be reported. Will also report to WHO
Information has been received from a physician's office and a 71 year old female consumer in a technical sales with a hx of similar rxn to products that contain formaldehyde who on 11FEB2003 was vaccinated IM with a 0.5 ml dos eof pneumococcal 23v polysaccharide vaccine. concomitant therapy included Levoxyl, generic Librax, Triamterene and lovastatin. There was no illness at the time of vaccination. Approximately three weeks after being vaccinated, the pt reported that her lips began to bubble, crack and peel. She reported that she tried chap stick, Blistex and antibiotic ointment but her condition had not improved. Her physician had not recommended any other treatment. No diagnostic studies were performed. It was reported that the physician's office did not see the pt regarding this event. Subsequently, the pt recovered. Additional information has been requested.
Over the initial 48-72 hrs following the injection I experienced soreness, swelling and redness of injection site, and soreness of the arm, and slight swelling of the general deltoid muscle. The injection site swelling and redness was about the size of a half dollar, raised resembling a hive, and had heat.  All these symptoms cleared after approximately 72 hours, but then the injection site redness, swelling and heat along with upper arm mild ache returned on 04/02/21 about 6-7 days after the injection.  Again, the redness is a raised areally about the size of a half dollar.
Body aches, fever, chills, sore arm, inability to walk after first dose. Second dose more severe symptoms. Headache, nausea, fatigue.
pt recv vax 14MAY98 & 19MAY98 pt exp afebrile sz & was hosp for 4 days;head CT scan was nl;EEG showed slowing w/bilat sharp waves;pt recovered from afeb sz but had residual sz disorder;
after his second Moderna vaccination (had previously received a Pfizer vaccination with negative antibodies), patient developed fever to 103 for three days, resolved.  However, on the night of his second vaccination, he developed severe pain in the right shoulder and upper arm (shot was given on the left) and several days later developed weakness in the arm.  Clinically, appears to have evidence of brachial plexitis.
general achiness (malaise); Flu like symptoms; Headache; Soreness in same arm of vaccine; His joints hurt; Was having difficulty swallowing; Feels like something stuck in his throat; Feels achy all over; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (Was having difficulty swallowing), OROPHARYNGEAL DISCOMFORT (Feels like something stuck in his throat), PAIN (Feels achy all over), MALAISE (general achiness (malaise)) and INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced DYSPHAGIA (Was having difficulty swallowing), OROPHARYNGEAL DISCOMFORT (Feels like something stuck in his throat), PAIN (Feels achy all over), ARTHRALGIA (His joints hurt) and VACCINATION SITE PAIN (Soreness in same arm of vaccine). On 04-Jan-2021, the patient experienced HEADACHE (Headache). On 06-Jan-2021, the patient experienced MALAISE (general achiness (malaise)) and INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, DYSPHAGIA (Was having difficulty swallowing), OROPHARYNGEAL DISCOMFORT (Feels like something stuck in his throat), PAIN (Feels achy all over), MALAISE (general achiness (malaise)), INFLUENZA LIKE ILLNESS (Flu like symptoms), ARTHRALGIA (His joints hurt), HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness in same arm of vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment for the event included acetaminophen and omeprazole.  This case concerns a 64 Y/O M with nonserious unexpected influenza like illness, malaise, pain, oropharyngeal discomfort, dysphagia and expected vaccination site pain, arthralgia and headache.  Event onset Day 6 after first dose mRNA-1273. Treated with acetaminophen and omeprazole. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Reporter's Comments: This case concerns a 64 Y/O M with nonserious unexpected influenza like illness, malaise, pain, oropharyngeal discomfort, dysphagia and expected vaccination site pain, arthralgia and headache.  Event onset Day 6 after first dose mRNA-1273. Treated with acetaminophen and omeprazole. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
SEVERE CHILLS AND ALL MUSCLES SPASMED FOR HOURS, EXTREME FATIQUE, HEADACHE, WEAKNESS IN MY LEGS. IT STARTED DURING THE NIGHT ON THURS OF THE SHOT. THE CHILLS AND SPASMS SUBSIDED BY FRIDAY MORNING.  I WAS EXHAUSTED AND WEAK AND SLEPT ALL BUT 4 HOURS ON FRIDAY. DURING FRIDAY NIGHT INTO SATURDAY MORNING I WOKE UP IN A DRENCHED SWEAT. BY SATURDAY MORNING I FELT BETTER BUT WAS STILL WEAK IN TO SUNDAY AFTERNOON. I WAS ABLE TO GO TO WORK ON MONDAY THE 19TH .
large local react @ site of inject induration aprox 8cm diameter, red & sore;
Passing out; ended up passing out hit her head very hard; had an allergic reaction; This is a spontaneous report from a contactable consumer(patient). A 38-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EP7533, Expiration date was not reported), via an unspecified route of administration on 01May2021 as dose 2, single (at the age of 38-years-old) for COVID-19 immunisation. Medical history included ongoing Crohn's disease and allergy and COVID-19 (prior vaccination) (from an unknown date and unknown if ongoing). Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication(s) included ustekinumab (Stelara) taken for Crohn's disease, start and stop date were not reported and patient took several other medications within 2 weeks of vaccination. Previously Patient received First dose of  BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: ER8737, Expiration date was not reported), via an unspecified route of administration on 06Apr2021 as dose 1, single (at the age of 38-years-old) for COVID-19 immunisation. Patient had not been tested for COVID-19, since the vaccination. On 08Jun2021, around 15:45 hours on Tuesday, patient took her ustekinumab (Stelara) injection for Crohn's disease, patient had taken this medication for years but this time patient had an allergic reaction around 5-10 mins after taking it and patient ended up passing out hit her head very hard, needed a Computerised tomogram (CT) scan. Patient was still needing liquid Benadryl multiple times a day now. Patient stated that ustekinumab (Stelara) takes a long time to get out of the body. Patient had emergency room/department or urgent care for the events. Patient do not know what her next steps will be. The only new thing that had happened was patient had her 2nd covid injection. Patient will see her health care providers next week. Patient will try to avoid the emergency room (ER). Patient do not want to pass out and hit my head again. The outcome of all the events was resolving.
Pt lost tone briefly after receiving his Flu and Mening B vaccines. MA was in the room at the time, but didn't witness the entire event as her back was turned to open the door for the patient and his mom. Per combined report of MA  and pt's mother he slumped slowly forward, falling to his knees and then sliding prone on the floor. His left temple grazed the wheel of the rolling chair, leaving him with a small abrasion with mild redness and swelling. After a few tonic-clonic jerks, he said he felt dizzy. It is not clear whether he lost consciousness for a few seconds or just felt dizzy. He was placed supine on the exam table. BP and HR were mildly elevated and he was pale. He felt better after sipping some soda with ice and an ice pack was applied to his temple. After a few minutes, he said he felt fine and ready to go. Mother reports that this has never happened before. Mother was given instructions to go to the ER for any vomiting or change in behavior/consciousness. Pt ambulated independently to car with Dr. and his mother.
excessive side effects; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (excessive side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history ).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (excessive side effects) (seriousness criterion hospitalization). At the time of the report, VACCINATION COMPLICATION (excessive side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drugs were not reported.No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
2 weeks to the day after Janssen vaccine spontaneous outbreak of hives all over body. Required steroid shot and oral burst dose of steroids for 7 days.  Hives present for 4 days with continued sporadic itching for several days after.
On the next day after the shot, I felt tired, had a dull headache, and was cold.  These symptoms continued the second day after the shot.
The vaccine activated sciatic nerve pain that I had in the past, I was unable to walk for several days. I did get treatment. Did physical therapy and had to get two epidural shots in spine
pain in shoulder/arm , limited mobility, numbness and tingling that radiates down from shoulder into forearm and wrist
Felt woozy, altered, barely able to concentrate.  Extreme fatigue in the evening.  Off balance, fell while going up stairs - have never fallen before this time.  Unable to work and stayed home, resting horizontally in bed.  Nausea and vomiting several times during the day.
My doctor had told me I only had arthritis in my neck.  The morning after the test we had the usual aches and pains we were told to expect.  I however had more bone pain than may husband.  It has progressively became more.  I have bone pain all the time.  Not just the joints, but the bones themselves as well.  Never in My life have I had a Vit D problem.  However the summer after the shot, I learned that my Vit D was severely low. I could barely function.  I now take it daily.
Pt. C/O HA in both temples rated at 6/10 - throbbing pain that continues. The pt. is also feeling febrile and developed neck pain with flexing neck. Per pt, Sx developed 15 minutes after receiving the PREVNAR-13 vaccination. He also stated that he had flushing in the face with a burning sensation that has subsided after taking BENADRYL. Patient presented to the ER.
Left arm at injection site is red and swollen and very sore.  Had fever of 102.5 all day yesterday (16 hours), couldn't break it with advil, but was able to reduce it to 100.2 for about 2 hours, before climbing right back up.  Very fatigued, slept all day. Today, slight fever of 99.5 and still fatigued but feeling much better than yesterday.
Flushing, anxious feeling.  Reported feeling flushed after 15 minutes.  Felt like having a panic attack.  Reports history of such.  BP 125/92, HR 115, RR 25 RA100%.  Provided water and rested. VS 122/88 HR 91. Symptoms resolved after an additional 30 minutes of monitoring.
error resulting in administration of expired vaccine; Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 17-Sep-2021, PRODUCT ADMINISTRATION ERROR (error resulting in administration of expired vaccine) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.
15-20 minutes after receiving the Tdap vaccine, patient had seizure-like activity. This activity occurred right after completion of a blood draw. Patient was sitting in the lab chair, the blood had just been collected when she voiced feeling light-headed. Her body became rigid and shaking. Her eyes were open, but not focused, nor tracking when I spoke with her. She did not respond. Her mouth was closed and had her chin tucked down to her chest. She was moving all around in the chair and there were 3 of us helping to keep her safe. This seizure-like activity lasted less than one minute. Within seconds she came back around, her body relaxed, and she was able to focus. Initially she was disoriented and after being reminded that she was the clinic, a few seconds later she remembered the blood draw. She was able to call her dad to meet her in the emergency room. She also reported that had soiled herself with urine.  She was escorted to the emergency room.
Pain at injection site R shoulder pain and very limited range of motion  Fatigue Chills Temp 100.5
Tightness in throat, palpations, HA, nausea, cleared by medics
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A 14-year-old female patient (not pregnant) received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# FD8448), at the age of 14, in right arm, on Aug 26, 2021, at 16:30, single dose, for COVID-19 immunization. No medical history or concomitant medications reported. The patient experienced vaccination site pain (pain at the injection site) and pain in extremity (arm pain), onset Aug 27, 2021, at 08:00, with outcome of recovered (Aug 27, 2021). No therapeutic measures taken. Additional information: The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, patient not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. No follow-up attempts possible. No further information expected.
Patient states she received spikevax vaccine  on 10/1/2023. By tuesday morning 10/3/23 she started getting low blood pressure symptoms and welts that started growing over her body roughly 48 hours after being vaccinated with spikevax. The welts started small and started to spread and she felt very itchy. She is since feeling much better.
Information has been received from a physician assistant concerning a 60 years or older female who was vaccinated with a dose of ZOSTAVAX (Merck) (0.65ml) on an unspecified date. One week later, the patient had an onset of neurological symptoms similar to Guillain-Barre syndrome. The patient was hospitalized at an unspecified hospital. The reporter stated that the AE "got better" but did not say if the patient had fully recovered or not. Additional information has been requested.
had shingles / got the shot afterward / about 6months later / had them again/ suspected vaccination failure; about 6months later / had them again; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (was back in early 90s).   On an unknown date, the patient received Shingles vaccine. On an unknown date, 6 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had shingles back in early 90s. The patient got the shingles shot and then about 6 months later, the patient had shingles again. The both shingles were light cases but miserable none the less. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. The follow up would not be possible as no contact details were available.
Information has been received from a licensed practical nurse referring to unspecified patients of unknown age and gender. On unspecified dates, the patients were vaccinated with RECOMBIVAX HB which has been exposed to temperatures outside of the recommended range, (lot # K017721, expiry date 27-AUG-2016; lot# K021444, expiry date 17-SEP-2016), (route, dose and frequency not reported). No adverse effects had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Nausea headache dizziness pain diarrhea crying. Patient taking tylenol and rehydrating with pedialyte
This spontaneous report as received from a nurse and refers to a patient of unknown age and gender. The patient's relevant medical history, concurrent conditions and concomitant medications were unknown. On 25-OCT-2018, the patient was vaccinated with an expired dose of PNEUMOVAX 23 lot # N005096 and expiration date 22-OCT-2018, for prophylaxis (dose strength, frequency, and route of administration were unknown). The patient experienced no adverse events. The outcome of expired product administered was unknown.
Narrative: 90yo male patient died during inpatient hospice care on 1/8/2022. Death was cause by: End stage dementia POA. Pt had received 3 covid vaccines on 1/15/21, 2/13/21, & 11/18/2021. This death is not related to covid vaccinations.
Case number PHEH2012US018683 is an initial spontaneous report received from a health care professional on 05 Sep 2012 with the follow-up received on 16 Oct 2012: This report refers to an 11-year-old female child. Her medical history included allergic to Amox and OMNICEF. She was vaccinated with MENVEO (batch number: M11082 and expiry date: 31 May 2014) intramuscularly in the right arm on 31 Aug 2012 at 15:15 pm. Concomitantly, she was also vaccinated with BOOSTRIX (other manufacturer, batch number: AC52B085BA) intramuscularly on 31 Aug 2012. The MENVEO vaccine had reached up to 11 degree Celsius for 30 to 60 minutes. No adverse event was reported following this administration error (incorrect storage of drug). Follow-up received on 16 Oct 2012: Updated patient height and weight, medical history, vaccine route of vaccination, site of vaccination, time of vaccination and concomitant vaccine.
Bursitis from vaccine. Poorly administered in wrong location with a needle that was possibly too long. Clinician did not  roll up my sleeve and examine my arm before choosing needle size. Cannot lift or use left arm after 1 week.